Evidence map›Paper›PMID 42312631›Full record

ArticleGenetics2026

Recombinant ubbR promoter enables highly efficient tamoxifen-inducible Cre recombination in embryonic and adult zebrafish.

Edita Bakūnaitė, Emilija Gečaitė, Samanta Žemalytė, Jaroslav Denkovskij, Justas Lazutka, Darius Balciunas

Abstract read
In one paragraph

Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edita BakūnaitėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.ORCID 0000-0003-2578-1619
Emilija GečaitėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.ORCID 0009-0002-7978-5359
Samanta ŽemalytėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.
Jaroslav DenkovskijInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.
Justas LazutkaInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.
Darius BalciunasInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT 10257, Lithuania.ORCID 0000-0003-1938-3243

Funding

European Social FundResearch Council of Lithuania
6 · The paper itself

Abstract

The ability to inactivate gene function in an adult organism is essential for studies of biological processes such as regeneration and behavior. This is best achieved by engineering an allele that could be conditionally inactivated using drug-inducible Cre recombinase. Several recent studies clearly demonstrate the feasibility of engineering such conditional alleles in zebrafish. Meanwhile, achieving a sufficient degree of recombination to induce complete loss of function has remained a major limitation. Herein, we address this limitation by engineering a recombinant ubiquitin promoter ubbR consisting of the zebrafish ubiquitin promoter supplemented with an intronic enhancer from the carp beta-actin2 gene. Using phiC31-mediated targeted integration, we demonstrate that ubbR outperforms both parental promoters at all embryonic stages tested. Furthermore, the ubbR:CreERT2 driver line we generated ensures a high-level recombination of floxed alleles in adult zebrafish tissues. Finally, we demonstrate that our ubbR promoter-driven construct retains high activity when integrated at other genomic loci, making this promoter a promising new tool for robust expression of transgenes at all stages of zebrafish ontogenesis.

Indexed as

IntegrasesPromoter Regions, GeneticRecombination, GeneticTamoxifenZebrafishAnimalsAnimals, Genetically ModifiedEmbryo, NonmammalianZebrafish ProteinsCre recombinaseIntegrasesTamoxifenZebrafish Proteinsconditional mutagenesisrecombinasetransgenesiszebrafish

Identifiers

PMID42312631
PMCPMC13535233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.